PolicyEMAMay 11
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 4-7 May 2026
The European Medicines Agency held its monthly safety meeting in May 2026 to review how medicines are being used and whether they're causing any unexpected side effects. The committee looked at new safety concerns and checked on medicines already approved in Europe to make sure they're still safe for patients.
WHY IT MATTERSIf you take a medicine approved in Europe, this committee's work directly affects whether that drug stays on the market or gets new safety warnings added to its label.
ℹ Good to know